Welcome to our dedicated page for Imax SEC filings (Ticker: IMAX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
IMAX Corporation filings document the formal records behind its entertainment-technology business, NYSE-listed common shares and reported operating results. Recent Form 8-K disclosures cover quarterly and annual financial results, global box office metrics, system installations and signings, material agreements and financing activity, including convertible senior notes.
Proxy materials describe board matters, executive compensation, equity awards and shareholder voting items. Other current reports address leadership-continuity and governance disclosures, while filings also identify the company as a Canadian corporation with operations reported through Content Solutions and Technology Products and Services.
IMAX Corporation’s Chief Legal & Sr Exec VP Robert D. Lister reported multiple equity compensation events. On March 7, 2026, vested restricted share units and performance stock units were converted into 36,950 common shares, reflecting previously granted awards.
To cover tax obligations on these conversions, IMAX withheld 51,159 common shares at $40.80 per share, which is recorded as a tax-withholding disposition rather than an open-market sale. Lister also received new equity awards, including 19,613 restricted share units and additional common share grants. After these transactions, he holds 204,875 common shares and 53,272 restricted share units directly.
IMAX CORP Chief Marketing Officer Anne Globe reported several equity compensation transactions dated March 7, 2026. She converted 12,225 and 5,500 vested restricted share units into the same number of common shares, reflecting routine settlement of prior awards. She also received a new grant of 12,512 restricted share units, each economically equivalent to one common share. To cover tax obligations related to the share delivery, IMAX Corporation withheld 6,904 common shares at $40.80 per share rather than selling them in the market. Following these transactions, Globe holds 18,574 common shares and 35,739 restricted share units in total.
IMAX Corporation describes its global premium cinema platform, highlighting record 2025 performance and expanded network reach. The company operates 1,864 IMAX systems in 91 countries and territories as of December 31, 2025, with 1,796 in commercial multiplexes and 434 systems in backlog.
In 2025, IMAX achieved a record $1.28 billion global box office, 13% above its prior 2019 record and 40% above the prior year, with its largest-ever film slate and 67 local-language releases. Local-language titles generated $405.4 million, or 32% of box office, and domestic market share reached 5.2% despite IMAX representing about 1% of domestic screens.
The filing details two operating segments—Content Solutions and Technology Products and Services—covering film remastering, distribution, premium projection systems, and maintenance. IMAX emphasizes international growth, especially in China and other non‑North American markets, along with brand extensions such as IMAX Enhanced streaming and live events. Extensive risk disclosures cover dependence on film performance, macroeconomic conditions, geopolitical tensions, cybersecurity, data privacy, tariffs, and heavy exposure to China.
IMAX Corporation reported record results for 2025, with total revenue of $410.2 million, up 16%, and net income attributable to common shareholders of $34.9 million, up 34%. Adjusted net income rose to $80.6 million and diluted adjusted EPS climbed to $1.45, an increase of 53%.
Full-year gross margin expanded to $246.2 million, or 60% of revenue, while total Adjusted EBITDA increased 33% to a record $184.9 million with a 45.1% margin. Global IMAX box office reached a best-ever $1.28 billion, and the company grew its commercial network to 1,796 multiplex systems with a backlog of 434.
Operating cash flow jumped 79% to a record $127.1 million, and free cash flow rose to $85.2 million. IMAX ended 2025 with $545 million in available liquidity and total debt of $289 million, and issued $250 million of 0.750% Convertible Senior Notes due 2030. Management’s 2026 guidance targets $1.4 billion in IMAX box office, 160 to 175 system installations, and adjusted EBITDA margin in the mid‑40% range.
Nomura Asset Management International Inc. and Nomura Investment Management Business Trust report beneficial ownership of 4,267,949 IMAX Corp common shares, representing 7.9% of the class. The stake is held with shared voting and dispositive power, and no sole voting or dispositive authority.
The firms state the IMAX shares were acquired and are held in the ordinary course of business, not to change or influence control of the company. The ownership percentage is based on 53,798,934 common shares outstanding as of September 30, 2025, as disclosed in IMAX’s Form 10-Q.
Orbis Investment Management Limited and Allan Gray Australia Pty Ltd report beneficial ownership of 5,151,721 IMAX Corp common shares, representing 9.6% of the class as of December 31, 2025.
Orbis holds 5,131,901 shares and Allan Gray 19,820 shares, each with sole voting and dispositive power over its block. Other persons have rights to receive dividends and sale proceeds on these securities. Both firms state the shares were acquired and are held in the ordinary course of business, not to change or influence control of IMAX. They are classified as non‑U.S. institutions equivalent to investment advisers and certify their foreign regulatory regimes are substantially comparable to U.S. standards.
Macquarie Group Limited and related entities filed an amended Schedule 13G reporting that they no longer beneficially own any Imax Corp common shares. As of 12/31/2025, Macquarie Group Limited, Macquarie Management Holdings Inc., and Macquarie Investment Management Business Trust each report 0 shares with 0.00% of the class.
The filing shows no sole or shared voting or dispositive power for any of the reporting persons, confirming that their ownership has fallen to 5 percent or less of Imax’s common shares. The firms also certify that any prior holdings were in the ordinary course of business and not for influencing control of Imax.
FMR LLC filed an amended Schedule 13G reporting beneficial ownership of 3,435,348.37 shares of IMAX Corporation common stock, representing 6.4% of the class as of 12/31/2025. FMR has sole voting power over 3,432,291 shares and sole dispositive power over 3,435,348.37 shares.
Abigail P. Johnson is also reported as a beneficial owner of the same 3,435,348.37 shares, with sole dispositive power and no voting power. The securities are certified as acquired and held in the ordinary course of business, not for the purpose of changing or influencing control of IMAX.
IMAX Corporation’s major shareholder group has updated its ownership disclosure in an Amendment No. 10 to Schedule 13D. Kevin Douglas reports beneficial ownership of 8,885,073 IMAX common shares, representing 16.5% of the company, based on 53,798,934 shares outstanding as of September 30, 2025. His wife, Michelle Douglas, reports 6,509,439 shares, or 12.1%, and James E. Douglas, III reports 1,363,645 shares, or 2.5%.
The filing details how these holdings are spread across multiple California trusts and Celtic Financial LLC, including the K&M Douglas Trust with 3,862,346 shares and several irrevocable descendant trusts each holding 646,110 or 646,111 shares. It explains that Kevin and Michelle Douglas act as co‑trustees on several of these entities and that Kevin Douglas manages Celtic Financial LLC, which holds 571,989 shares. The amendment also notes that the filers have not executed any IMAX share transactions in the last 60 days.
IMAX Corporation chief executive officer and director Richard L. Gelfond reported multiple equity transactions on January 2, 2026 involving IMAX common shares and restricted share units. Vested restricted share units were converted into common shares at an exercise price of $0.00, and a portion of those shares was withheld at a price of $36.02 per share to cover related tax obligations. Following these transactions, Mr. Gelfond beneficially owns 635,940 IMAX common shares directly, along with outstanding equity awards consisting of 1,818,695 options and 231,562 restricted share units. The restricted share units are scheduled to vest in installments through January 2, 2029, each unit representing the right to receive one IMAX common share.